cbdMD, Inc. (AMEX: YCBD) Q2 Earnings: Revenue Growth Amidst EPS Miss in the Cannabinoid Market

Font: Financial Modeling Prep  • May 15, 2026

• Revenue Beat: cbdMD, Inc. (AMEX: YCBD) exceeded analyst revenue expectations, reporting $5.64 million for Q2 2026, driven by core business growth and acquisitions.
• EPS Miss & Unprofitability: Despite strong revenue performance, the company posted an earnings per share of -$0.08, missing estimates and indicating unprofitability with a negative P/E ratio.
• Financial Stability: cbdMD demonstrates robust financial health with a low debt-to-equity ratio of 0.044 and a strong current ratio of 2.82, suggesting solid liquidity.

cbdMD, Inc. (AMEX: YCBD) is a prominent wellness company that operates several brands in the rapidly expanding cannabinoid industry. These include cbdMD, Bluebird Botanicals, Paw CBD, and the THC beverage brand Oasis. On May 14, 2026, the company reported its second-quarter earnings, providing key insights into its financial performance and market position, which showed a mix of positive and negative results compared to analyst expectations.

The cannabinoid stock posted revenue of $5.64 million, impressively surpassing the analyst consensus estimate of $5.29 million. This represents a significant 19% year-over-year and 12% sequential revenue growth. This increase was primarily driven by cbdMD's core business operations and the recent strategic acquisition of Bluebird Botanicals, as highlighted by PR Newswire, underscoring the company's growth initiatives in the competitive wellness market.

Despite the strong revenue performance, YCBD announced an earnings per share of -$0.08, which unfortunately missed the analyst estimate of -$0.05. This unprofitability is also reflected in its negative earnings yield of -103.83% and a trailing price-to-earnings (P/E) ratio of -0.01. A negative P/E ratio indicates that a company has negative earnings, a crucial metric for investors evaluating profitability.

From a valuation perspective, YCBD has a price-to-sales (P/S) ratio of 0.0015. The P/S ratio compares a company's stock price to its revenues, and a low ratio can sometimes suggest that a stock is undervalued relative to its sales, offering potential investment opportunities. The company's enterprise value-to-operating cash flow is 1.45, another important valuation metric for financial analysis.

However, the company shows strong financial stability, a positive sign for long-term investors. YCBD maintains a low debt-to-equity ratio of 0.044, demonstrating that it does not rely heavily on debt financing. Furthermore, its current ratio of 2.82 suggests a robust capacity to cover its short-term obligations, as it holds $2.82 in assets for every $1 in liabilities due soon, indicating excellent liquidity management.